Technology: Biotechnology, Health Care, Therapeutics
Industry: End-to-end Drug Development
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2016-01-01
Employees Number: 101-250
Funding Status: IPO
Acquisitions Number: 1
Investors Number: 12
Total Funding: 1170000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-09-12
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership